IsoRay Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | IsoRay Inc.

IsoRay Inc. | Mutual Funds

Mutual Funds that own IsoRay Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

833,336

1.24%

07/31/2018

Vanguard Extended Market Index Fund

792,772

1.18%

186,878

07/31/2018

Bridgeway Ultra Small Company Market Fund

218,700

0.33%

0.03%

12/31/2017

Fidelity Spartan Extended Market Index Fund

212,731

0.32%

07/31/2018

Fidelity Spartan Total Market Index Fund

57,047

0.09%

07/31/2018

Vanguard Balanced Index Fund

43,614

0.07%

07/31/2018

iShares Core S&P Total US Stock Market ETF

32,510

0.05%

09/06/2018

17,247

0.03%

09/05/2018

BlackRock Master Extended Market Index Series

15,938

0.02%

01/31/2018

Vanguard Invt. Fds. ICVC - US Equity Index Fund

7,100

0.01%

06/30/2018

About IsoRay

View Profile

Address	350 Hills Street Richland Washington 99354 United States
Employees	-
Website	http://www.isoray.com
Updated	07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.